As of 4:32:18 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-14,173.0000
-15,119.0000
11,976.0000
-10,754.0000
-24,786.0000
Investing Cash Flow
-473.0000
2,384.0000
-12,005.0000
4,026.0000
21,118.0000
Financing Cash Flow
4,112.0000
-776.0000
-282.0000
-1,033.0000
-826.0000
End Cash Position
6,016.0000
8,674.0000
22,224.0000
22,417.0000
30,033.0000
Capital Expenditure
-8,219.0000
-664.0000
-1,007.0000
-125.0000
-484.0000
Repayment of Debt
--
--
--
--
-284.0000
Free Cash Flow
-22,392.0000
-15,783.0000
10,969.0000
-10,879.0000
-25,270.0000
12/31/2020 - 6/30/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANW.SG Immuron Ltd
0.0570
-0.87%
YP1A.MU Immutep Ltd
1.9800
-4.81%
XMP0.MU Plus Therapeutics Inc
0.9540
-2.75%
YP1B.SG Immutep Ltd
0.1970
0.00%
YP1A.DU Immutep Ltd. R
2.0000
-2.91%
ANWA.DU Immuron Ltd. R
1.8800
+1.08%
UKJ2.F Opthea Limited
3.0600
+2.68%
EFY.MU PharmaCyte Biotech Inc
22.50
0.00%
ZVA.MU Cellectis SA
1.5060
-3.83%
ETXPF e-therapeutics plc
0.1300
0.00%